Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen, Myriad Genetics, Beckman Coulter

Premium
Qiagen’s Artus CMV PCR Kit last week received the CE certification for diagnostic use in the European Union, and the company said that the kit is available immediately.
 
The Artus kits are intended for early quantitative detection of CMV, and are suitable for use with the ABI Prism 7000, 7700, and 7900HT SDS, LightCycler 1.1/1.2/1.5/2.0 Instruments, as well as Rotor-Gene 3000.
 

 
Myriad Genetics last week launched its BRACAnalysis Rearrangement Test for detecting rare, large rearrangements of DNA in the BRCA1 and BRCA2 genes. The test is intended to be performed on samples from women with exceptionally high risk, and who have tested negative for sequence mutations and the common large rearrangements already included in Myriad's test.
 

 
Beckman Coulter this week launched its Agencourt RNAdvance Tissue system for total RNA isolation from mammalian samplesusing paramagnetic bead nucleic acid purification technology. The system produces clean RNA with high recovery in a single tube or in 96-well formats, the company said.
 
The system can be automated on the Beckman Coulter Biomek NX liquid handling workstation, and it can produce RNA for microarray experiments when coupled with Agencourt RNACleantechnology.

Filed under

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.